RECRUITING

Maternal Abdominal Morphology Assessment

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Previous studies have shown that pancreas size tends to be smaller in individuals with diabetes compared to those without diabetes. The investigators have recently found that pancreas size increases during pregnancy. The MAMA study aims to examine changes in the pancreas that occur during pregnancy, in both pregnant mothers and their babies, and find out how they are affected by maternal diabetes. The MAMA study is a prospective cohort study that will follow women and their babies through pregnancy and one year postpartum. Women aged 18-54, who are under 14 weeks pregnant are being recruited to participate in the MAMA study.

Official Title

Diabetes Prediction During Pregnancy Using Pancreas MRI

Quick Facts

Study Start:2025-05-06
Study Completion:2031-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06784674

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 54 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * Pregnant women, with a singleton gestation
  2. * Age 18 - 54 years at screening
  3. * Gestational age \< 14 weeks
  4. * Willing to commit to 1 year postpartum follow up
  5. * Planning to remain in geographical vicinity of Austin for 1 year after delivery
  1. * Presence of any mechanically or magnetically activated implants
  2. * Claustrophobia
  3. * Other contraindication for MRI
  4. * BMI ≥ 35.0 or maximum width less than 48 cm (necessary to fit within the MRI field of view)

Contacts and Locations

Study Contact

Jack Virostko, Ph.D.
CONTACT
512-495-5126
jack.virostko@austin.utexas.edu
Ingrid Harris, MPH
CONTACT
512-471-0999
ingrid.harris@austin.utexas.edu

Principal Investigator

Jack Virostko, Ph.D.
PRINCIPAL_INVESTIGATOR
University of Texas at Austin

Study Locations (Sites)

Dell Medical School Health Discovery Building
Austin, Texas, 78701
United States

Collaborators and Investigators

Sponsor: University of Texas at Austin

  • Jack Virostko, Ph.D., PRINCIPAL_INVESTIGATOR, University of Texas at Austin

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-05-06
Study Completion Date2031-12

Study Record Updates

Study Start Date2025-05-06
Study Completion Date2031-12

Terms related to this study

Keywords Provided by Researchers

  • Pregnancy
  • Pancreas
  • Diabetes

Additional Relevant MeSH Terms

  • Pregnancy Related
  • Infant Development
  • Pancreas
  • Diabetes